Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Filings indexed 532 across all filing types
Latest filing 2020-06-09 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Trading Update
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Omega Diagnostics Group PLC. It provides a 'Trading update' covering business developments, supply agreements, and financial expectations for the year ended 31 March 2020. While it contains financial information, it is an initial announcement of highlights and operational updates rather than the full annual report or a formal earnings release. It also includes a 'Notice of Results' section. Given the nature of the content as a general regulatory announcement regarding company operations and trading status, it fits best under the RNS category.
2020-06-09 English
Update on progress of UK-Rapid Test Consortium
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Omega Diagnostics Group PLC regarding the progress of the UK-Rapid Test Consortium. It provides a corporate update on a specific project (COVID-19 test development) and includes a press release from the consortium. It does not fit into specific categories like financial reports, dividend notices, or director dealings, and serves as a general regulatory update on company activities. Therefore, it is classified as a Regulatory Filing (RNS).
2020-06-03 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This specific document type is explicitly defined in the filing categories as 'Major Shareholding Notification' (Code: MRQ).
2020-06-01 English
Exercise of Options and TVR
Share Issue/Capital Change Classification · 1% confidence The document is an RNS announcement from Omega Diagnostics Group PLC regarding the allotment of 45,000 new ordinary shares following the exercise of share options. It explicitly mentions the total number of voting rights and the admission of these new shares to trading on AIM. This falls under the category of share capital changes and new share issues.
2020-05-28 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for Omega Diagnostics Group PLC. It is a market-related regulatory announcement concerning trading mechanics rather than a financial report, management update, or corporate action. As it does not fit into specific categories like dividends, M&A, or director dealings, it falls under the general regulatory filing category.
2020-05-28 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange regarding a 'Price Monitoring Extension' for Omega Diagnostics Group PLC. It is distributed via the RNS (Regulatory News Service) and does not contain financial statements, management reports, or other substantive corporate disclosures. As it is a standard regulatory notification regarding trading mechanics that does not fit into specific categories like dividends or share issues, it is classified as a general regulatory filing.
2020-05-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.